Sanofi Consumer Healthcare India Limited, a prominent player in the consumer healthcare sector, has announced a significant change in its leadership team. The company has appointed Richard D'souza as its new Chief Financial Officer (CFO), effective October 16, 2025. This strategic move, approved by the Board of Directors, aims to strengthen the company's financial leadership and drive future growth.

Appointment Details

The appointment of Richard D'souza comes after careful consideration by the company's Board of Directors, based on recommendations from the Nomination and Remuneration Committee and in consultation with the Audit Committee. This decision underscores Sanofi's commitment to maintaining strong financial governance and strategic financial management.

Richard D'souza: A Seasoned Financial Expert

Richard D'souza brings a wealth of experience to his new role at Sanofi Consumer Healthcare India. Here's a closer look at his impressive background:

Impact on Sanofi Consumer Healthcare India

The appointment of Richard D'souza as CFO is expected to bring several benefits to Sanofi Consumer Healthcare India:

1. Strategic Financial Leadership: With his extensive experience in financial strategy and M&A, D'souza is well-positioned to guide Sanofi's financial decisions and growth initiatives.

2. Enhanced Governance: His background in corporate governance and investor relations may strengthen Sanofi's financial transparency and stakeholder communications.

3. Digital Transformation: D'souza's expertise in digital transformation could potentially drive technological advancements in Sanofi's financial operations.

4. Industry Insights: His experience in the FMCG and consumer goods sectors aligns well with Sanofi's consumer healthcare focus, potentially bringing valuable industry-specific insights.

The appointment of Richard D'souza as CFO marks an important step for Sanofi Consumer Healthcare India as it continues to strengthen its position in the competitive consumer healthcare market. Stakeholders will likely be watching closely to see how his expertise and leadership will contribute to the company's financial strategies and overall growth in the coming years.

Sanofi Consumer Healthcare India Limited has announced a significant change in its senior management. Chief Financial Officer (CFO) Narahari Naidu has tendered his resignation to pursue new career opportunities outside the organization.

Key Details of the Resignation

Company's Disclosure

The company, in compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, has formally notified both the BSE Limited and the National Stock Exchange of India Limited about this change in senior management.

Naidu's Farewell

In his resignation email, Naidu expressed his gratitude towards the organization, stating, "It has been a privilege and an honour to serve this esteemed organisation. I am deeply grateful for the trust and support extended to me by each member of the Board, the senior leadership team, and my colleagues across the Company."

Impact and Next Steps

While the departure of a key executive like the CFO can be significant for any organization, Sanofi Consumer Healthcare India Limited has not yet announced a successor or interim arrangement for the CFO position. The company's board and management will likely be focusing on ensuring a smooth transition as they search for Naidu's replacement.

This development comes at a time when the pharmaceutical and healthcare sectors are navigating complex market dynamics. Investors and industry observers will be keenly watching how Sanofi Consumer Healthcare India Limited manages this transition and its potential impact on the company's financial strategy and performance.

As the company moves forward, stakeholders will be interested in any updates regarding the search for a new CFO and any potential shifts in financial strategy or management that may result from this change in leadership.